New findings support novel combination treatment for head and neck cancers

Human papillomavirus (HPV)-negative head and neck squamous cell carcinoma (HNSCC) and lung cancer can have disruptive mutations in TP53 and/or CDKN2A tumor suppressor genes, which are associated with poor patient survival.

Leave A Comment

Your email address will not be published. Required fields are marked *